These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24363446)

  • 1. Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.
    Shapiro S; deVilliers TJ; Pines A; Sturdee DW; Archer DF; Baber RJ; Panay N; Farmer RD; Stevenson JC; Mueck AO; Burger HG; Gompel A
    J Natl Cancer Inst; 2014 Feb; 106(2):djt372. PubMed ID: 24363446
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of estrogen plus progestin hormone therapy on breast cancer mortality: still unresolved.
    Schairer C; Brinton LA
    J Natl Cancer Inst; 2013 Apr; 105(8):513-4. PubMed ID: 23543780
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
    Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
    J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing concepts: Menopausal hormone therapy and breast cancer.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2012 Apr; 104(7):517-27. PubMed ID: 22427684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer: the role of hormone therapy.
    Creasman WT
    Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Archer DF; Bush T; Nachtigall LE
    J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
    [No Abstract]   [Full Text] [Related]  

  • 9. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context.
    Chlebowski RT; Aragaki AK
    Menopause; 2023 Apr; 30(4):454-461. PubMed ID: 36727752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone therapy and breast cancer risk.
    Foidart JM; Desreux J; Pintiaux A; Gompel A
    Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.
    Colditz GA
    Breast Cancer Res; 2007; 9(4):108. PubMed ID: 17666116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Garton M
    Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement and breast cancer: implications of the Iowa Women's Health Study.
    Mayer ME
    Cleve Clin J Med; 1999; 66(10):608-10, 613. PubMed ID: 10598365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
    Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
    J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen, estrogen plus progestin therapy, and risk of breast cancer.
    Colditz GA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):909s-17s. PubMed ID: 15701886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestrogens and progestins and breast cancer risk in post-menopausal women.
    La Vecchia C
    Pharmacol Res; 1995 Dec; 32(6):323-4. PubMed ID: 8736479
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
    Li CI; Weiss NS; Stanford JL; Daling JR
    Cancer; 2000 Jun; 88(11):2570-7. PubMed ID: 10861435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.